Clinical Trial Update: Evaluating an Ebola and a Marburg Vaccine in Uganda [Phase 1]

View source ↗

Summary

A Phase 1 trial conducted in Uganda evaluated Ebola and Marburg vaccines. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease
• Marburg Virus Disease

Drugs mentioned

• Ebola vaccine (unspecified)
• Marburg vaccine (unspecified)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus Disease, Marburg Virus Disease | Phase 1 | Status: COMPLETED